US Patent Issued to Impact Therapeutics (Shanghai) on Feb. 10 for "Solid pharmaceutical formulation of PARP inhibitors and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,378, issued on Feb. 10, was assigned to Impact Therapeutics (Shanghai) Inc (Shanghai).

"Solid pharmaceutical formulation of PARP inhibitors and use thereof" was invented by Suixiong Cai (Shanghai) and Yushen Guo (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a solid pharmaceutical formulation of PARP inhibitors and its use thereof, and more specifically a solid dispersion powder including 5-fluoro-1-(4-fluoro-3-(4-(pyrimidin-2-yl)piperazine-1-carbonyl)benzyl)quinazoline-2,4(1H,3H)-dione and polymers, wherein the content of polymers is from about 50 wt % to about 80 wt %, and wherein less than 10 wt % of 5-flu...